Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments

Autor: Michael Überall, Irmgard Bösl, Els Hollanders, Ingo Sabatschus, Mariëlle Eerdekens
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: BMJ Open Diabetes Research & Care, Vol 10, Iss 6 (2022)
Druh dokumentu: article
ISSN: 2022-0030
2052-4897
DOI: 10.1136/bmjdrc-2022-003062
Popis: Introduction Painful diabetic peripheral neuropathy (PDPN), a common complication of diabetes mellitus, is challenging to treat. Efficacy and tolerability of the topical lidocaine 700 mg medicated plaster (LMP) and well-established first-line oral medications (OM) were compared in refractory PDPN patients.Research design and methods This is a subgroup analysis of a non-interventional, retrospective 24-week cohort study using anonymized routine medical care data from the German Pain eRegistry. Propensity score matching provided 732 datasets per treatment group. Primary effectiveness endpoint was the absolute change in average 24-hour Pain Intensity Index (0–100 mm) from baseline after 4, 12 and 24 weeks of treatment and over the entire treatment period.Results The majority of this multimorbid and polymedicated study population of patients with PDPN had suffered pain for more than a year and presented with a high pain burden despite a median of seven previous analgesic medications. LMP treatment resulted in significant reductions in pain intensity and improvements in daily functioning already after 4 treatment weeks. Effectiveness was maintained over the treatment period even when concomitant analgesics were reduced or discontinued and quality of life improved. Mean change in the primary effectiveness parameter over the 24-week treatment period was −30.2 mm (SE 0.38) and −17.0 mm (SE 0.51) in the LMP and OM groups, respectively. Improvements in all effectiveness parameters were significantly greater under LMP than under OM treatment (p
Databáze: Directory of Open Access Journals